"The ISO-13485 certification confirms our strategic focus and our mindset of quality in digital engineering. Software as a medical device is a digital transformation enabler for key players in life sciences and healthcare. Be it for big diagnostics or pharma producers, laboratories, pharmacies, hospitals, or even the actual medical practices, the opportunities this type of software represents are innumerable. The digital link between consumers and providers is already evident in many industries today, but we are yet to see this in life sciences and healthcare," said Andrei Doibani, managing director and dead of the Life Sciences & Healthcare Business Unit, Nagarro.
The certification reinforces Nagarro's excellence in the field of highly regulated software, such as medical device software, and opens the road to additional service and solution developments in the life sciences and healthcare space. Nagarro has obtained this certification from TÜV Süd, one of the world's leading inspection organizations on safety, security, and sustainability solutions.
As life sciences and healthcare companies face ever more stringent regulations, the ISO-13485 certification guarantees the necessary quality that is critical for any product development in this area.
In an era of digital transformation and disruption, Nagarro prides itself on a history of partnerships with some of the biggest biotech and pharma groups globally. Nagarro's team of global experts brings with them a clear understanding of the needs, constraints, and opportunities this industry faces.